The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
The UC San Diego Health System acquired the Nevada Cancer Institute
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
Rock and Roll Hall of Fame inductee Alice Cooper played a benefit concert at OMRF
On Jun. 24, 2012, Rock and Roll Hall of Fame inductee Alice Cooper helped raise $675,500 for the…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Comprehensive Cancer Center received NCI designation
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut
In 2012, Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut. Today,…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Non-Profit Research | Oncology | Therapeutics
Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream Team
On Dec. 14, 2011, Patricia M. LoRusso, D.O., of the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan;…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
The Monroe Cancer Center opened
On Sept. 2, 2011, the Monroe Cancer Center opened as a joint venture between Karmanos Cancer Institute, Mercy…
Disease | FDA | Life Science News | Oncology
The FDA approved Seattle Genetics’ Adcetris (brentuximab vedotin)
On Aug. 19, 2011, the U.S. Food and Drug Administration (FDA) approved Seattle Genetics’ Adcetris (brentuximab vedotin), making…
Genentech drug Zelboraf (vemurafenib) was approved
On Aug. 16, 2011, the U.S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for…
Disease | Life Science History | Life Science News | Medicine | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center performed its 5,000th bone marrow transplant
On Aug. 9, 2011, the Siteman Cancer Center announced that it had performed its 5,000th bone marrow transplant,…
TomoTherapy acquired by Accuray
On Jun. 13, 2011, Accuray announced it had completed its acquisition of TomoTherapy. The combination creates the premier…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
University Hospitals Seidman Cancer Center opened
On Jun. 6, 2011, University Hospitals (UH) Seidman Cancer Center, Northeast Ohio’s first and only freestanding cancer hospital,…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Jon M and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer Institute
On Apr. 21, 2011, Jon M. and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer…
Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million
On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Jane and Lee Seidman donated $42 million to University Hospitals for Cancer Center
On Nov. 30, 2010, Jane and Lee Seidman have donated $42 million to University Hospitals (UH) – the…
Biotechnology | Diagnostics | Disease | Life Science History | Life Science News | Oncology | Radiology | Therapeutics | U.S. Congress
The Radiation Exposure Compensation Amendments of 1999 was signed into law
On Jul. 7, 2010 the Radiation Exposure Compensation Amendments of 1999 (P.L. 106-245) was passed by the U.S….
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Oncology | Women's Health
Siteman Cancer Center received NCI SPORE grant to study endometrial cancer
On Mar. 5, 2010, the National Cancer Institute (NCI) announced that it had awarded the Siteman Cancer Center…
Pacific Health Research & Education Institute became successor-in-interest to Pacific Health Research Institute
In 2010, the Pacific Health Research & Education Institute (PHREI) became the successor-in-interest to Pacific Health Research Institute….
The Jon M Huntsman family donated $125 million to the Huntsman Cancer Institute
On Apr. 26, 2000, Jon M. Huntsman, a billionaire industrialist, announced that he would give $125-million to a…
Smilow Cancer Hospital opened for patient care
On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with María Rosa Menocal, a Yale…
FDA approved new indication for gardasil to prevent genital warts in men and boys
On Oct. 16, 2009, the U.S. Food and Drug Administration (FDA) approved new indication for gardasil to prevent…
Dr. Brian Druker honored with Lasker Award
On Sept. 16, 2009, Brian J. Druker, M.D.,whose research led to the development of Gleevec, the first targeted…
Pfizer collaborated on landmark $6 million oncology research project with the Ontario Institute for Cancer Research
On Jul. 15, 2009, Pfizer with the Ontario Institute for Cancer Research (OICR) and the Ontario Cancer Institute…
Biotechnology | Diagnostics | Life Science News | Medicine | Non-Profit Research | Oncology | Therapeutics
USC purchased Norris Cancer Hospital and University Hospital (now Keck Hospital) from Tenet Healthcare
On Apr. 1, 2009, the University of Southern California (USC) purchased Norris Cancer Hospital and University Hospital (now…
The Hollings Cancer Center was designated a Cancer Institute
On Mar. 2, 2009, the Hollings Cancer Center was designated a Cancer Institute. National Cancer Institute (NCI) designation…
The Hollings Cancer Center received NCI-designation
On Mar. 2, 2009, the Hollings Cancer Center (HCC) received National Cancer Institute (NCI) designation. Hollings’ mission is…
Emory University’s Chemical Biology Discovery Center became part of the NCI Chemical Biology Consortium (CBC)
In Mar. 2009, Emory University’s Chemical Biology Discovery Center became part of the NCI Chemical Biology Consortium (CBC),…
Lung oncology expert Alan Sandler, MD joined the Knight Cancer Institute
On Jan. 21, 2009, the Knight Cancer Institute announced the recruitment of lung oncology expert Alan Sandler, M.D.,…
Surgeon Chris Amling, MD joined the Knight Cancer Institute
On Jan. 20, 2009, the Knight Cancer Institute announced the recruitment of surgeon Chris Amling, M.D., chief of…
Stanford researchers discovered the first human bladder cancer stem cell
On Aug. 3, 2009, Researchers at Stanford’s School of Medicine announced they had identified the first human bladder…